Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Thrombocythemia, Essential D013920 9 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Sheehan DV et al. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. 1984 J Clin Psychopharmacol pmid:6142907
Barnett AH et al. Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes. 1984 Lancet pmid:6145027
Schenkelaars EJ and Bonta IL Beta 2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophages. 1984 Eur. J. Pharmacol. pmid:6151905
Giani E et al. Sex differences in platelet thromboxane and arterial prostacyclin production in control and n-6 fatty acid supplemented rats. 1984 Prostaglandins pmid:6441187
Kopolovic R et al. Effects of ibuprofen on a porcine model of acute respiratory failure. 1984 J. Surg. Res. pmid:6708494
Teng CM et al. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom. 1984 Biochim. Biophys. Acta pmid:6426517
Schenkein HA and Rutherford B C3-mediated release of prostaglandin from human monocytes. Behaviour in short-term culture. 1984 Immunology pmid:6690398
Hsueh W et al. Identification of C3b as the major serum protein that stimulates prostaglandin and thromboxane synthesis by macrophages. 1984 Prostaglandins pmid:6240667
De Clerck F et al. Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine. 1984 Agents Actions pmid:6543415
Menys VC and Davies JA Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben). 1984 Lab. Invest. pmid:6546403
Pedersen AK et al. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha. 1984 Thromb. Res. pmid:6546456
Novo S et al. Platelet activity in relation to smoke and exercise in patients with chronic obstructive lung disease: effects of platelet antiaggregating drugs. 1984 Adv. Exp. Med. Biol. pmid:6546467
Ford WD et al. Congenital diaphragmatic hernia: association between pulmonary vascular resistance and plasma thromboxane concentrations. 1984 Arch. Dis. Child. pmid:6546658
Rosenblum WI and Hirsh PD Some interrelationships between glucose levels thromboxane production and prostacyclin production in normal and diabetic mice. 1984 Prostaglandins pmid:6546804
Saldeen P et al. Thromboxane production in umbilical vein grafts. 1984 Thromb. Res. pmid:6546814
Bush LR et al. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. 1984 Circulation pmid:6546902
Wilson TW et al. Determination of 6-keto-prostaglandin F1 alpha and thromboxane B2 in urine by high-performance liquid chromatography and radioimmunoassay. 1984 J. Chromatogr. pmid:6546935
Ylikorkala O et al. Maternal thromboxane, prostacyclin, and umbilical blood flow in humans. 1984 Obstet Gynecol pmid:6546976
Hamasaki Y et al. Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. 1984 Am. Rev. Respir. Dis. pmid:6547031
Gallenkämper W et al. Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia. 1984 Br. J. Pharmacol. pmid:6547067
Coker SJ and Parratt JR The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion. 1984 Br. J. Pharmacol. pmid:6547068
Brown CG and Poyser NL Studies on the control of prostaglandin production by the hypothalamus in relation to LH release in the rat. 1984 J. Endocrinol. pmid:6593408
Romero SD et al. Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man. 1984 J. Neurochem. pmid:6593432
Fantone JC et al. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. 1984 Am. J. Pathol. pmid:6324595
Benedetto C et al. Production of prostacyclin, 6-keto-PGF1 alpha and thromboxane B2 by incubated samples of umbilical vessels: a comparison of methods for expressing the results on dry weight, wet weight, protein or DNA bases. 1984 Prostaglandins pmid:6390522
FitzGerald GA and Oates JA Selective and nonselective inhibition of thromboxane formation. 1984 Clin. Pharmacol. Ther. pmid:6370554
Welton AF et al. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases. 1984 J. Pharmacol. Exp. Ther. pmid:6198511
Navran SS et al. Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. 1984 Thromb. Res. pmid:6372157
Furman BL et al. Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats. 1984 Br. J. Pharmacol. pmid:6375795
Kääpä P et al. Thromboxane B2 production by fetal and neonatal platelets: effect of idiopathic respiratory distress syndrome and birth asphyxia. 1984 Pediatr. Res. pmid:6472947
Gachályi B et al. In vitro effect of cimetidine on ADP induced platelet aggregation and thromboxane A2 synthesis in man. 1984 Thromb. Res. pmid:6474407
Gross S and Worthington-White DA The effects of PGF2 alpha, PGI2, and TxB2 on human CFU-C in healthy and leukemic patients. 1984 Am. J. Hematol. pmid:6372442
Fitzpatrick F et al. Development of a gas chromatographic-mass spectrometric method using a stable isotope internal standard for quantitation of thromboxane B2. 1984 Thromb. Res. pmid:6474413
Watanabe J et al. Effect of vitamin E on platelet aggregation in diabetes mellitus. 1984 Tohoku J. Exp. Med. pmid:6474447
Prinz RA et al. Platelet activation by human pancreatic fluid. 1984 J. Surg. Res. pmid:6482425
Wilson L and Huang LS Temporal response of uterine prostaglandins to estradiol treatment in the ovariectomized-pregnant rat. 1984 Prostaglandins pmid:6484214
Walinsky P et al. Thromboxane A2 in acute myocardial infarction. 1984 Am. Heart J. pmid:6485997
Brown C et al. Effects of age and steroid treatment on prostaglandin production by the rat uterus in relation to implantation. 1984 J. Reprod. Fertil. pmid:6583409
Luderer JR et al. Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon. 1984 Clin. Pharmacol. Ther. pmid:6428793
Ishii H et al. The effect of plasma on platelet function in hypercholesterolemic rabbits and the changes in fatty acid composition of the plasma. 1984 Thromb. Res. pmid:6234679
D'Angelo A et al. Increased production of platelet thromboxane B2 in non-insulin-dependent diabetes. Relationship to vascular complications. 1984 Eur. J. Clin. Invest. pmid:6428908
Del Maschio A et al. Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites. 1984 Eur. J. Pharmacol. pmid:6432556
Schenkein HA and Rutherford RB Effects of serum on C3b-stimulated release of prostaglandins and thromboxane B2 from human monocytes. 1984 Immunopharmacology pmid:6511367
Kawai C New horizons in cardiology. 1984 Int. J. Cardiol. pmid:6334040
Hänsch GM et al. Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. 1984 J. Immunol. pmid:6432907
Messmore HL et al. Molecular markers of platelet activation. 1984 Semin. Thromb. Hemost. pmid:6240115
Hornych A et al. [Changes in plasma prostaglandins in normal subjects in an orthostatic position. Comparison with the response of the renin-aldosterone system]. 1984 Presse Med pmid:6242503
Rachmilewitz D and Karmeli F Effect of nufenoxole on human colonic prostanoid synthesis, Na-K-ATPase and adenylate cyclase activities. 1984 Eur. J. Pharmacol. pmid:6152213
De Caterina R et al. Inhibition of platelet function by injectable isosorbide dinitrate. 1984 Am. J. Cardiol. pmid:6428211
Stock JL and Coderre JA Calcitonin enhances production of prostaglandins by stimulated human monocytes. 1984 Prostaglandins pmid:6087420
Triolo G et al. Circulating immune complexes and platelet thromboxane synthesis in patients with insulin-dependent (type I) diabetes mellitus. 1984 Diabetes pmid:6611280
Yui Y et al. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. 1984 Circulation pmid:6434196
Koike K et al. Platelet secretion defect in patients with the attention deficit disorder and easy bruising. 1984 Blood pmid:6692042
Jackson CA et al. Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus. 1984 Clin. Sci. pmid:6434224
Vesterqvist O et al. Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. 1984 Thromb. Res. pmid:6695361
Davì G et al. Platelet function changes in acute myocardial infarction. 1984 Adv. Exp. Med. Biol. pmid:6695571
Mehta J et al. Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina. 1984 Am. Heart J. pmid:6695662
Klotz TA et al. Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease. 1984 Chest pmid:6697787
Alster P and Wennmalm A Effect of nicotine on the formation of prostacyclin-like activity and thromboxane in rabbit aorta and platelets. 1984 Br. J. Pharmacol. pmid:6367870
Girotti MJ et al. Effects of immunization on cardiopulmonary alterations of gram-negative endotoxemia. 1984 J Appl Physiol Respir Environ Exerc Physiol pmid:6368499
Dembinska-Kieć A et al. Formation of leukotriene C4-like material by rat brain tissue. 1984 Eur. J. Pharmacol. pmid:6426980
Schieppati A et al. The metabolism of arachidonic acid by platelets in nephrotic syndrome. 1984 Kidney Int. pmid:6434788
Hutton RA et al. Assessment of platelet function in patients with Raynaud's syndrome. 1984 J. Clin. Pathol. pmid:6229551
Ditter H et al. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma. 1984 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:6083951
Stuart MJ et al. Effects of hyperoxia and hypoxia on vascular prostacyclin formation in vitro. 1984 Pediatrics pmid:6435087
Tanganelli I et al. Effects of somatostatin on the behavior of thromboxane B2 and B-thromboglobulin in type 1 diabetes. 1984 Boll. Soc. Ital. Biol. Sper. pmid:6084513
Vergani CG et al. Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease). 1984 Eur. J. Clin. Invest. pmid:6421598
Ylikorkala O et al. Peritoneal fluid prostaglandins in endometriosis, tubal disorders, and unexplained infertility. 1984 Obstet Gynecol pmid:6232475
Schultze G et al. Effect of cyclosporine on the generation of prostanoids by cultured peripheral lymphocytes. 1984 Transplant. Proc. pmid:6592863
Zipser RD et al. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. 1984 Gastroenterology pmid:6593268
Koskimies AI et al. Peritoneal fluid 6-keto-prostaglandin F1 alpha, thromboxane B2 in endometriosis and unexplained infertility. 1984 Acta Obstet Gynecol Scand Suppl pmid:6594012
Branski D et al. Prostaglandins in small intestinal mucosa of children with celiac disease. 1984 J. Pediatr. Gastroenterol. Nutr. pmid:6594493
Woodcock BE et al. The platelet defect in acute myeloid leukaemia. 1984 J. Clin. Pathol. pmid:6595273
Ogushi F et al. [In vitro release of arachidonate metabolites by human alveolar macrophages]. 1984 Nihon Kyobu Shikkan Gakkai Zasshi pmid:6595434
Bommer J et al. Plastic filing from dialysis tubing induces prostanoid release from macrophages. 1984 Kidney Int. pmid:6595463
Brandt R et al. Effect of propranolol, practolol and atenolol on human platelet thromboxane formation and plasma levels of prostaglandins 6-keto-F1 alpha and E2. 1984 Prostaglandins Leukot Med pmid:6597450
Chiba S et al. Sex and age-related differences in the urinary excretion of TXB2 in normal human subjects: a possible pathophysiological role of TXA2 in the aged kidney. 1984 Prostaglandins Leukot Med pmid:6597456
Mahmud I et al. Thromboxane synthesizing system in rat liver. 1984 Prostaglandins Leukot Med pmid:6597457
Morrison AR and Crowley JR Identification of an unusual cyclooxygenase metabolite of arachidonic acid in rabbit renal medulla. 1984 Arch. Biochem. Biophys. pmid:6437329
Stimler NP Spasmogenic activity of C5adesArg anaphylatoxin on guinea pig lung parenchymal strips: sensitivity of the leukotriene-mediated component to cyclooxygenase inhibitors. 1984 Biochem. Biophys. Res. Commun. pmid:6440564
Mallarkey G and Smith GM In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs. 1984 Br. J. Pharmacol. pmid:6423018
Wang JP et al. XC 386: a new antiplatelet agent. 1984 Thromb. Res. pmid:6438827
Schafer AI et al. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. 1984 J. Clin. Invest. pmid:6423665
Driss F et al. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. 1984 Thromb. Res. pmid:6098051
Fuller RW et al. Dexamethasone inhibits the production of thromboxane B2 and leukotriene B4 by human alveolar and peritoneal macrophages in culture. 1984 Clin. Sci. pmid:6091982
Dahl ML and Uotila P Salicylate does not interfere with aspirin in human blood in vivo. 1984 Prostaglandins Leukot Med pmid:6585840
Henke DC et al. Analysis of leukotrienes, prostaglandins, and other oxygenated metabolites of arachidonic acid by high-performance liquid chromatography. 1984 Anal. Biochem. pmid:6091494
Dahl ML and Uotila P Thromboxane formation during blood clotting is decreased by verapamil. 1984 Prostaglandins Leukot Med pmid:6585842
Hall ER et al. The reduction of potential TXB2 levels when serum is preincubated at room temperature. 1984 Prostaglandins Leukot Med pmid:6585846
Codde JP et al. Validation of the direct radioimmunoassay of prostanoids in serum and kidney. 1984 Prostaglandins Leukot Med pmid:6587406
Shaala S et al. Local effect of thromboxane B2 on the contractility of the human non pregnant uterus. 1984 Prostaglandins Leukot Med pmid:6587408
Higgins AJ et al. Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudate. 1984 Cornell Vet pmid:6587959
Meydani M et al. Effects of dietary methionine, methylmercury, and atrazine on ex-vivo synthesis of prostaglandin E1 and thromboxane B2. 1984 Prostaglandins Leukot Med pmid:6588393
Branski D et al. Effect of cimetidine on human gastric and duodenal prostanoid synthesis. 1984 Scand. J. Gastroenterol. pmid:6589742
Galli C et al. Acute effects of ethanol, caffeine, or both on platelet aggregation, thromboxane formation, and plasma-free fatty acids in normal subjects. 1984 Drug Nutr Interact pmid:6510241
Lelcuk S et al. Inhibition of ischemia-induced thromboxane synthesis in man. 1984 J Trauma pmid:6325720
Swart SS et al. Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. 1984 Thromb. Res. pmid:6326344
Turk J et al. Arachidonic acid metabolism in isolated pancreatic islets. I. Identification and quantitation of lipoxygenase and cyclooxygenase products. 1984 Biochim. Biophys. Acta pmid:6329307
Gal D et al. Effect of radiation on prostaglandin production by human bowel in vitro. 1984 Int. J. Radiat. Oncol. Biol. Phys. pmid:6588048
Oglesby TD and Gorman RR The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor. 1984 Biochim. Biophys. Acta pmid:6424715